UnitedHealth Group Shares Plummet Amid Report of Federal Medicare Fraud Investigation

UnitedHealth Group, the largest health insurer in the United States, saw its shares tumble on Thursday following a report that the company is under federal investigation for potential Medicare fraud.

According to a Wall Street Journal article citing anonymous sources, the U.S. Department of Justice (DOJ) has been conducting a criminal probe into the company’s Medicare Advantage operations since mid-2024. This revelation sent UnitedHealth Group’s stock into a downward spiral, plunging 16.5% in early trading on the New York Stock Exchange. The company’s valuation has now been slashed by nearly 50% since the beginning of the year.

UnitedHealth Group Shares Plummet Amid Report of Federal Medicare Fraud Investigation

Leadership Exit and Uncertainty Around Financial Forecast

The news comes just days after UnitedHealth Group announced that its Chief Executive Officer, Sir Andrew Witty, will step down for what the company described as “personal reasons.” In a related development, the firm suspended its full-year financial outlook, citing “higher-than-anticipated medical expenses” as a key factor.

This one-two punch of regulatory scrutiny and executive turnover has sparked alarm among investors and analysts, further destabilizing the company’s public standing.

Company Denies Formal Notification of Criminal Probe

In response to the Wall Street Journal report, UnitedHealth Group issued a strong rebuttal.

“We have not been notified by the Department of Justice of the supposed criminal investigation reported, without official attribution, in the Wall Street Journal today,” the company said in a statement.

The company further defended its operations, stating:

“We stand by the integrity of our Medicare Advantage program.”

While the DOJ has not publicly confirmed the investigation, the implications for UnitedHealth Group—should the allegations prove credible—could be profound, particularly given the scale of its Medicare-related business.

Mounting Scrutiny Over Medicare Advantage

Medicare Advantage is a privatized extension of Medicare in which private insurers like UnitedHealth Group contract with the federal government to provide healthcare coverage. These programs have come under increasing scrutiny for alleged overbilling and denial of care.

Earlier this year, the Wall Street Journal reported that a civil fraud investigation was already underway into UnitedHealth Group‘s Medicare billing practices. In a separate move, U.S. Senator Chuck Grassley launched a congressional inquiry into the company’s billing methodology, demanding transparency and detailed compliance documents.

UnitedHealth Group Shares Plummet Amid Report of Federal Medicare Fraud Investigation

A String of Setbacks and Security Concerns

This challenging period for UnitedHealth Group began in December 2024, when company executive Brian Thompson was tragically shot and killed outside a hotel in New York City. While the incident remains under investigation, it added a layer of tragedy to the company’s ongoing corporate troubles.

Over the years, UnitedHealth Group has leveraged its dominant position in the healthcare and insurance markets to expand aggressively, especially within the Medicare Advantage space. This strategy has made the company a giant in U.S. healthcare, but it has also exposed it to growing regulatory and political pressures.

Justice Department Silent Amid Market Turmoil

As of Thursday afternoon, the Department of Justice has not commented on the report. Without confirmation or denial from the DOJ, the market remains on edge, and UnitedHealth Group faces a period of heightened scrutiny.

Conclusion: A Pivotal Moment for UnitedHealth Group

The unfolding events represent a pivotal moment for UnitedHealth Group, whose future now hangs in the balance amid legal uncertainty, investor anxiety, and public scrutiny. The combination of a potential federal investigation, executive upheaval, and mounting political pressure could reshape not just the company’s operations, but the broader Medicare Advantage landscape in the U.S.

Stakeholders, regulators, and the public alike will be watching closely as more details emerge about the Justice Department’s investigation into UnitedHealth Group.

📢 Stay Ahead with Reliable Reporting

For real-time updates and in-depth news coverage on health, business, politics, and more, trust Hours of News — your reliable source for hour-by-hour updates across every major sector.

Related posts

Hero Firefighter Dad Gives Liver Transplant for Baby Daughter and Saves Her Life

FDA Warns Seniors to Avoid Chikungunya Vaccine After Fatal Complications

Eric Stonestreet Weight Loss: ‘Modern Family’ Star Talks Mounjaro, Health, and Breaking Stigma